These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25387264)

  • 1. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.
    Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.
    Farber CR; Reich A; Barnes AM; Becerra P; Rauch F; Cabral WA; Bae A; Quinlan A; Glorieux FH; Clemens TL; Marini JC
    J Bone Miner Res; 2014 Jun; 29(6):1402-11. PubMed ID: 24519609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.
    Blouin S; Fratzl-Zelman N; Glorieux FH; Roschger P; Klaushofer K; Marini JC; Rauch F
    J Bone Miner Res; 2017 Sep; 32(9):1884-1892. PubMed ID: 28548288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
    Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
    Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.
    Zhytnik L; Maasalu K; Duy BH; Pashenko A; Khmyzov S; Reimann E; Prans E; Kõks S; Märtson A
    Hum Genomics; 2019 Jun; 13(1):25. PubMed ID: 31159867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.
    Marom R; Song IW; Busse EC; Washington ME; Berrier AS; Rossi VC; Ortinau L; Jeong Y; Jiang MM; Dawson BC; Adeyeye M; Leynes C; Lietman CD; Stroup BM; Batkovskyte D; Jain M; Chen Y; Cela R; Castellon A; Tran AA; Lorenzo I; Meyers DN; Huang S; Turner A; Shenava V; Wallace M; Orwoll E; Park D; Ambrose CG; Nagamani SC; Heaney JD; Lee BH
    J Clin Invest; 2024 Jun; 134(15):. PubMed ID: 38885336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
    Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC
    Bone; 2022 Sep; 162():116451. PubMed ID: 35654352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation.
    Lietman CD; Marom R; Munivez E; Bertin TK; Jiang MM; Chen Y; Dawson B; Weis MA; Eyre D; Lee B
    J Bone Miner Res; 2015 Mar; 30(3):489-98. PubMed ID: 25251575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFITM5 mutations and osteogenesis imperfecta.
    Hanagata N
    J Bone Miner Metab; 2016 Mar; 34(2):123-31. PubMed ID: 26031935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype study in type V osteogenesis imperfecta.
    Balasubramanian M; Parker MJ; Dalton A; Giunta C; Lindert U; Peres LC; Wagner BE; Arundel P; Offiah A; Bishop NJ
    Clin Dysmorphol; 2013 Jul; 22(3):93-101. PubMed ID: 23612438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination.
    Patoine A; Gaumond MH; Jaiswal PK; Fassier F; Rauch F; Moffatt P
    J Bone Miner Res; 2014 Sep; 29(9):2004-16. PubMed ID: 24715519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset.
    Hoyer-Kuhn H; Semler O; Garbes L; Zimmermann K; Becker J; Wollnik B; Schoenau E; Netzer C
    J Bone Miner Res; 2014 Jun; 29(6):1387-91. PubMed ID: 24293101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.
    Grover M; Campeau PM; Lietman CD; Lu JT; Gibbs RA; Schlesinger AE; Lee BH
    J Bone Miner Res; 2013 Nov; 28(11):2333-7. PubMed ID: 23674381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.
    Semler O; Garbes L; Keupp K; Swan D; Zimmermann K; Becker J; Iden S; Wirth B; Eysel P; Koerber F; Schoenau E; Bohlander SK; Wollnik B; Netzer C
    Am J Hum Genet; 2012 Aug; 91(2):349-57. PubMed ID: 22863195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.
    Maranda V; Gaumond MH; Moffatt P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.
    Takeyari S; Kubota T; Ohata Y; Fujiwara M; Kitaoka T; Taga Y; Mizuno K; Ozono K
    J Biol Chem; 2021; 296():100027. PubMed ID: 33154166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients.
    Rauch F; Moffatt P; Cheung M; Roughley P; Lalic L; Lund AM; Ramirez N; Fahiminiya S; Majewski J; Glorieux FH
    J Med Genet; 2013 Jan; 50(1):21-4. PubMed ID: 23240094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.
    Jovanovic M; Guterman-Ram G; Marini JC
    Endocr Rev; 2022 Jan; 43(1):61-90. PubMed ID: 34007986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon IFITM5 mutation associated with severe skeletal deformity in osteogenesis imperfecta.
    Rodriguez Celin M; Moosa S; Fano V
    Ann Hum Genet; 2018 Nov; 82(6):477-481. PubMed ID: 30039845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta.
    Guillén-Navarro E; Ballesta-Martínez MJ; Valencia M; Bueno AM; Martinez-Glez V; López-González V; Burnyte B; Utkus A; Lapunzina P; Ruiz-Perez VL
    Am J Med Genet A; 2014 May; 164A(5):1136-42. PubMed ID: 24478195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.